FDA’s Vinay Prasad says he will ‘rapidly’ push forward rare disease advances

The FDA’s new head of biologics Vinay Prasad said he plans to “rapidly make available” even small advances in rare disease treatments, a sign of flexibility that undercuts earlier perceptions of Prasad as potentially bringing …